Atherectomy and Thrombectomy Devices Market
Number of pages: 100 | Report Format: PDF | Published date: 08 February, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
US$ 3.46 billion |
|
Revenue forecast in 2030 |
US$ 6.25 billion |
|
Growth Rate |
CAGR of 6.8% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments covered |
Type, Application, and Region. |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global atherectomy and thrombectomy devices market was valued at US$ 3.46 billion in 2021 and is expected to witness a CAGR of 6.8% during the forecast period from 2022 to 2030.
Market Fundamental
Atherectomy is used to eradicate atherosclerotic plaque from injured arteries. To address the shortcomings of balloon angioplasty, atherectomy and thrombectomy were developed in the 20th century. Different atherectomy devices are made to cut, shave, sand, or vaporize these plaques, along with indications. Furthermore, thrombectomy is a procedure used to remove clots in acute myocardial infarction (MI) and, pulmonary embolism (PE), acute cerebral ischemic stroke. In the case of thrombectomy, an endovascular device is used in a mechanical interventional treatment to remove a blood clot or thrombus by using image guidance. Devices for atherectomy and thrombectomy are crucial in the medical field since they can safely eliminate plaque from blocked arteries. These devices break down plaque accumulation by a combination of mechanical and chemical procedures, enabling the restoration of healthy blood flow. These devices have already been shown to be a crucial part of minimally invasive treatments for cardiovascular disease, even if there is still more study to be done on them. These devices are also employed in other medical specialties, including the treatment of peripheral artery disease and stroke. It most frequently employs catheter-based procedures, such as direct aspiration, stent retrieval, or a mix of the two. Atherectomy and thrombectomy devices either crush the plaques and clots into tiny pieces so they can embolize distally or cut and remove atherosclerotic plaque and thrombotic clots from a vascular wall. After atherectomy and thrombectomy, the lumen is enlarged without straining the artery wall, which reduces elastic recoil.
[46463633]
Market Dynamics
The increasing incidence of atherosclerosis and thrombosis is the key driver of the global atherectomy and thrombectomy devices market. Due to the rise in chronic illnesses, the demand for less invasive technologies, high-tech improvements, user-friendliness, and market entrants. Atherosclerosis and thrombosis are caused by the global increase in the geriatric population, lifestyle-related changes, and genetic abnormalities within the population base, offering growth potential to the market. The adoption of cutting-edge technology is also anticipated to give the industry a growth platform. Examples include the introduction of laser and ultraviolet radiation, recombinant tissue technology, and 3D image production. Additionally, advantages such as quick recovery, less incisions, less bleeding and scarring, a greater surgical success rate, little trauma, and post-operative problems are the major factors propelling the global atherectomy and thrombectomy devices market. Furthermore, atherectomy and thrombectomy devices possess many advantages, such as the low risk of complications, no vessel wall injury, effective in rebuilding vessel patency, unmasking fundamental abscess, enabling the targeted treatment, does not require lysis drug and vessel preparation, requiring only a brief hospital stay, does not require intensive care unit stay, is simple to use, and cost-effective. These factors solely contribute to the faster expansion of the global market with a larger revenue. In the upcoming years, the acceptance of minimally invasive procedures, the rising prevalence of cardiovascular illnesses, and technological improvements in atherectomy and thrombectomy devices are expected to cause considerable growth in the global market for these devices. The government's increasing efforts to raise public knowledge of the advantages of using these devices are also anticipated to contribute to the market's expansion. For those involved in this sector, the rising desire for affordable solutions is anticipated to bring about new opportunities.
However, there are still kinking issues with ineffective thrombectomy in angled and sclerotic aortic bifurcations, potential risk of vessel wall dissection and perforation in highly calcified vessels, high costs for catheter systems. The possibility of distal embolization within indications for thrombectomy or lysis therapy, the lack of a catheter device for below-the-knee thrombectomy, and a minimal lumen vessel of 4 mm, also harm the market expansion.
Market Ecosystem
The global atherectomy and thrombectomy devices market is analysed from three perspectives: Type, Application, and Region.
Atherectomy and Thrombectomy Devices Market by Type
[64352342]
Based on the type the global atherectomy and thrombectomy devices market is divided into rheolytic, aspiration, rotational and ultrasound device. The rotational devices segment of the market held the largest market revenue in 2021. Several key advantages of using rotation atherectomy and thrombectomy devices are responsible for the increased growth of the segment. Rotational atherectomy is the safest option when the arteries are significantly calcified or obstructed. Rotational atherectomy and thrombectomy devices are advanced medical technologies that have revolutionized cardiovascular diseases treatments. These devices use rotational forces to remove blockages in the arteries by using a spinning burr or blade, allowing blood to flow more freely. This has proven to be a safe and effective treatment for coronary artery disease, peripheral arterial disease, and other cardiovascular conditions.
Furthermore, the rotational atherectomy and thrombectomy devices can also be used to improve balloon angioplasty results and reduce restenosis rates. In comparison to balloon angioplasty, rotational atherectomy and thrombectomy of ostial lesions increases procedural and clinical success and lessen the need for side-branch intervention. Rotational devices and stenting together had better restenosis rates than stenting alone in these ostial lesions. It has also been suggested as a treatment for fibrocalcific plaque-containing undeletable abrasions. Rotational atherectomy and thrombectomy can improve lesion compliance and make it more receptive to later adjunct balloon angioplasty and/or stent administration and placement by partially rupturing the fibrocalcific plaque. More than 90% of reported rotational procedures for this kind of tumour were successful. Rotational type devices have a solid place in our interventional toolbox for treating difficult and severely calcified lesions because it makes the treatment quick and easy without affecting restenosis or long-term clinical outcomes.
Atherectomy and Thrombectomy Devices Market by Application
Based on the application, the global atherectomy and thrombectomy devices market is classified as hospitals, clinics, and others. The hospital segment dominated the global market in 2021. Hospitals took the lead as they have more operating capital to invest in cutting-edge medical technologies. Hospitals hold essential medical equipment to offer patients complete care because they are frequently multi-specialty centers. The increasing use of atherectomy for the treatment of peripheral and cardiac vascular diseases, ongoing technological developments in the field of minimally invasive or image-guided atherectomy procedures, rising rates of chronic vascular diseases, and expanding access to healthcare reimbursements in many developed nations are all factors that contribute to this segment's significant market share. The rising geriatric population across the globe is expected to be one of the major drivers for thrombectomy & atherectomy procedures over the forecast period.
Atherectomy and Thrombectomy Devices Market by Region
Based on the regional outlook, the global atherectomy and thrombectomy market is expended over North America, Europe, Asia Pacific, and the rest of the world. In North America, the atherectomy and thrombectomy market had the highest CAGR in 2021. Due to significant reasons like an increasing frequency of cardiovascular diseases, high disposable income, an advanced diagnostic system, frequent lifestyle-related changes, and an increase in the elderly population, North America held the highest proportion. Government campaigns to raise awareness and sophisticated infrastructure significantly contribute to the market's expansion over the forecast period. Additionally, the existence of well-established healthcare facilities, kind reimbursement systems, and rising patient awareness levels contribute to its substantial share.
The Asia Pacific region is predicted to have the quickest market growth, largely because of expanding disposable income, bettering healthcare infrastructure, and raising patient awareness. Affluent growth is projected in the Asia Pacific over the forecast period due to increased patient knowledge of the many CVD treatment options available and quickly developing healthcare infrastructure in growing nations like China and India. Further driving regional growth throughout the predicted period will be an increase in government measures aimed at lowering rates of cardiovascular disease (CVD), together with increased disposable income.
Competitive Landscape
The key companies holding the largest share of the global atherectomy and thrombectomy devices market are,
Strategic Development
Atherectomy and thrombectomy devices remove clots and plaques in acute myocardial infarction (MI), pulmonary embolism (PE), and acute cerebral ischemic stroke.
The key trends governing the global atherectomy and thrombectomy devices market are, increasing atherosclerosis and thrombosis, increased chronic illness, increased demand for less invasive technologies, technological improvements, increased geriatric population.
The most important companies dominating the global atherectomy and thrombectomy market are, Medtronic PLC, Boston Scientific, Abbott Laboratories, Koninklijke Philips N.V., Johnson & Johnson (J&J), Bayer AG, Argon Medical Devices, Inc., Getinge AB, Straub Medical AG, Terumo Corporation, Uscom Ltd., Teleflex Incorporated, Sorin Group USA Inc., and Ventracor Ltd., among others
The potential risk of vessel wall dissection and perforation in highly calcified vessels, high costs for catheter systems, the possibility of distal embolization within indications for thrombectomy or lysis therapy, the lack of a catheter device for below-the-knee thrombectomy, and a minimal lumen vessel of 4 mm, are the restraining factor for global atherectomy and thrombectomy devices market.
The global atherectomy and thrombectomy devices market is expected to witness a CAGR of 6.8% during the forecast period fromm 2022 to 2030.
*Insights on financial performance are subject to the availability of information in the public domain
Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.
GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.
Snehal Deshmukh
Principle Consultant
Speak to analyst